PLC-γ1 Enzyme Activity Is Required for Insulin-Induced DNA Synthesis.

J. Eichhorn,A. Kayali,Laura Resor,D. A. Austin,D. Rose,N. Webster
DOI: https://doi.org/10.1210/endo.143.2.8621
IF: 5.051
2002-02-01
Endocrinology
Abstract:Previously, we had shown that inhibition of PLC activity impaired the ability of insulin to activate ERK in 3T3-L1 adipocytes. In this study, we confirmed that the insulin receptor and PLC-1 are physically associated in hIRcB fibroblasts, insulin stimulates PLC-1 enzyme activity, and inhibition of PLC activity impairs activation of ERK. We subsequently investigated whether PLC-1 is required for insulin-stimulated mitogenesis. First, inhibition of PLC activity using U73122 impairs the ability of insulin to stimulate DNA synthesis. Second, disruption of the interaction of the insulin receptor with PLC-1 by microinjection of SH2 domains derived from PLC-1 or Grb2 but not Shc similarly blocks insulin-induced DNA synthesis. Third, microinjection of neutralizing antibodies to PLC-1 blocks DNA synthesis, but nonneutralizing antibodies do not. The blockade in all three cases is rescued by synthetic diacylglycerols but not by inositol-1,4,5trisphosphate, indicating a requirement for PLC enzyme activity. These experimental data point to a requirement for PLC-1 in insulin-stimulated mitogenesis in hIRcB cells. (Endocrinology 143: 655– 664, 2002)
What problem does this paper attempt to address?